Related Experiment Video
Updated: Jun 24, 2025

07:27
Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
Published on: October 6, 2016
10.2K
Assessing the Efficacy of the ARMOR Tool-Based Deprescribing Intervention for Fall Risk Reduction in Older Patients
Rekha Priyadarshini1, Madhavi Eerike1, Sakthivadivel Varatharajan2
1Department of Pharmacology, All India Institute of Medical Sciences Bibinagar, Hyderabad, India.
JMIR Research Protocols
|June 11, 2024
Summary
This study evaluates the ARMOR tool for deprescribing fall risk-increasing drugs (FRIDs) in older adults. It assesses fall reduction and cost-effectiveness, aiming to improve geriatric care and safety.
Area of Science:
- Geriatric Medicine
- Pharmacology
- Health Economics
Background:
- Falls in older adults lead to severe health issues and increased healthcare costs.
- Fall Risk-Increasing Drugs (FRIDs) contribute significantly to fall incidents in the elderly.
- Deprescribing offers a strategy to manage polypharmacy and mitigate medication-related risks.
Purpose of the Study:
- To determine the effectiveness of the ARMOR tool in reducing falls among older patients on FRIDs.
- To evaluate the cost-effectiveness of deprescribing FRIDs using the ARMOR intervention.
- To provide evidence for optimizing geriatric care and fall prevention strategies.
Main Methods:
- An open-label, randomized controlled trial involving individuals aged 60-80 years on multiple medications, including FRIDs.
- Stratified randomization of physicians to implement deprescribing with the ARMOR tool.
- Comprehensive data collection including fall history, medication review, and validated fall risk assessments (Timed Up and Go, Tinetti).
Main Results:
- Efficacy measured by fall frequency and changes in fall risk assessment scores.
- Cost-effectiveness analysis including incremental cost-effectiveness ratio (ICER).
- Monitoring of adverse events related to deprescribing interventions.
Conclusions:
- The ARMOR tool shows promise in reducing falls in the geriatric population using FRIDs.
- Deprescribing FRIDs is likely a cost-effective strategy for improving health outcomes in older adults.
- Findings will inform healthcare professionals and policymakers on fall prevention and medication management in the elderly.

